Obesity pandemic – searching for the most effective treatments

Abstract Obesity develops as a result of excessive fat tissue accumulation caused by a chronic state of positive energy balance. The increased accumulation of fat in the muscles, heart and liver leads to the development of type 2 diabetes, cardiovascular disease and a wide range of metabolic disorders. In this literature review, we would like to elucidate the methods used in the treatment of overweight/obesity and demonstrate the most effective strategy. A balanced diet with an appropriate calorie deficit is a critical element in obesity management. Diets recommended for reducing cardiovascular risk include the Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH) and vegetarian diets. Weight loss also depends on total daily energy expenditure. Regular physical activity induces body weight reduction, declines cardiovascular risk and alleviates chronic diseases. Meta-analyses pertinent to weight loss programs showed that there is greater weight loss as a result of a combination of diet and physical activity compared to only one of these methods. Obesity treatment should also include appropriate psychological support, including psychoeducation, social support and behavioral intervention. If there are no effects of non-pharmacological treatment, pharmacological therapy should be implemented to treatment. The following drugs are registered for obesity treatment in the European Union: orlistat, extended-release naltrexone (ER)/bupropion (ER) and glucagon-like peptide-1 (GLP-1 RA) receptor agonists – liraglutide and semaglutide. It should be emphasized that pharmacotherapy significantly increases the effectiveness of the treatment in people previously treated non-pharmacologically previuosly. In recent years, there has been a gradual increase in the number of bariatric surgeries performed for obesity management. However, bariatric procedures are associated with numerous serious complications and high treatment costs. To sum up, the most effective strategy with relatively few side effects includes combined therapy based on dietary intervention, lifestyle modification and pharmacotherapy.

Authors

Institutions

Publication Details

Journal
Biuletyn Głównej Biblioteki Lekarskiej
Published
2024-12-01
DOI
https://doi.org/10.2478/bgbl-2024-0028
Citations
1
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Obesity pandemic – searching for the most effective treatments

Klaudia Kołakowska
1 citations
Biuletyn Głównej Biblioteki Lekarskiej
Pharmacology and Obesity Treatment
0.45
article

Obesity pandemic – searching for the most effective treatments

Klaudia Kołakowska
article en
1 citations

Abstract

Abstract Obesity develops as a result of excessive fat tissue accumulation caused by a chronic state of positive energy balance. The increased accumulation of fat in the muscles, heart and liver leads to the development of type 2 diabetes, cardiovascular disease and a wide range of metabolic disorders. In this literature review, we would like to elucidate the methods used in the treatment of overweight/obesity and demonstrate the most effective strategy. A balanced diet with an appropriate calorie deficit is a critical element in obesity management. Diets recommended for reducing cardiovascular risk include the Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH) and vegetarian diets. Weight loss also depends on total daily energy expenditure. Regular physical activity induces body weight reduction, declines cardiovascular risk and alleviates chronic diseases. Meta-analyses pertinent to weight loss programs showed that there is greater weight loss as a result of a combination of diet and physical activity compared to only one of these methods. Obesity treatment should also include appropriate psychological support, including psychoeducation, social support and behavioral intervention. If there are no effects of non-pharmacological treatment, pharmacological therapy should be implemented to treatment. The following drugs are registered for obesity treatment in the European Union: orlistat, extended-release naltrexone (ER)/bupropion (ER) and glucagon-like peptide-1 (GLP-1 RA) receptor agonists – liraglutide and semaglutide. It should be emphasized that pharmacotherapy significantly increases the effectiveness of the treatment in people previously treated non-pharmacologically previuosly. In recent years, there has been a gradual increase in the number of bariatric surgeries performed for obesity management. However, bariatric procedures are associated with numerous serious complications and high treatment costs. To sum up, the most effective strategy with relatively few side effects includes combined therapy based on dietary intervention, lifestyle modification and pharmacotherapy.

Biuletyn Głównej Biblioteki LekarskiejVol. 57(383)
Medical University of Białystok (PL)
Openalex Percentile: Top 28%
Pharmacology and Obesity Treatment
0.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.